Avalon Investment & Advisory’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $15.6M | Buy |
210,163
+908
| +0.4% | +$76.1K | 0.43% | 73 |
|
|
2022
Q4 | $19.5M | Sell |
209,255
-229,865
| -52% | -$22.2M | 0.56% | 58 |
|
|
2022
Q3 | $41.9M | Sell |
439,120
-79,313
| -15% | -$7.85M | 1.3% | 22 |
|
|
2022
Q2 | $48M | Sell |
518,433
-10,965
| -2% | -$1.07M | 1.35% | 20 |
|
|
2022
Q1 | $53.6M | Buy |
529,398
+6,866
| +1% | +$721K | 1.29% | 26 |
|
|
2021
Q4 | $53.9M | Sell |
522,532
-68,101
| -12% | -$6.29M | 1.33% | 24 |
|
|
2021
Q3 | $50.1M | Sell |
590,633
-28,161
| -5% | -$2.36M | 1.16% | 29 |
|
|
2021
Q2 | $51.6M | Sell |
618,794
-42,869
| -6% | -$3.51M | 1.15% | 27 |
|
|
2021
Q1 | $49.8M | Buy |
661,663
+86,444
| +15% | +$6.3M | 1.14% | 24 |
|
|
2020
Q4 | $39.3M | Sell |
575,219
-14,024
| -2% | -$912K | 0.8% | 36 |
|
|
2020
Q3 | $34.4M | Sell |
589,243
-27,416
| -4% | -$1.71M | 0.76% | 40 |
|
|
2020
Q2 | $40.1M | Sell |
616,659
-56,510
| -8% | -$3.56M | 0.92% | 30 |
|
|
2020
Q1 | $39.9M | Buy |
673,169
+25,880
| +4% | +$1.73M | 1.02% | 24 |
|
|
2019
Q4 | $48.1M | Buy |
647,289
+47,699
| +8% | +$3.35M | 0.98% | 25 |
|
|
2019
Q3 | $37.8M | Buy |
599,590
+253,402
| +73% | +$15M | 0.83% | 30 |
|
|
2019
Q2 | $18.9M | Buy |
346,188
+103,208
| +42% | +$5.56M | 0.42% | 78 |
|
|
2019
Q1 | $13.1M | Sell |
242,980
-3,640
| -1% | -$225K | 0.3% | 116 |
|
|
2018
Q4 | $16.2M | Buy |
246,620
+145,575
| +144% | +$10.9M | 0.42% | 69 |
|
|
2018
Q3 | $7.95M | Sell |
101,045
-1,052
| -1% | -$75.2K | 0.22% | 146 |
|
|
2018
Q2 | $6.57M | Sell |
102,097
-2,175
| -2% | -$143K | 0.19% | 143 |
|
|
2018
Q1 | $6.49M | Sell |
104,272
-684
| -0.7% | -$49.1K | 0.2% | 141 |
|
|
2017
Q4 | $7.61M | Sell |
104,956
-1,870
| -2% | -$136K | 0.24% | 133 |
|
|
2017
Q3 | $8.69M | Buy |
+106,826
| New | +$8.45M | 0.28% | 125 |
|
|
2017
Q1 | – | Sell |
-80,565
| Closed | -$6.36M | – | 356 |
|
|
2016
Q4 | $6.36M | Sell |
80,565
-4,600
| -5% | -$372K | 0.23% | 121 |
|
|
2016
Q3 | $7.58M | Sell |
85,165
-115,435
| -58% | -$10.9M | 0.29% | 110 |
|
|
2016
Q2 | $19.2M | Buy |
200,600
+5,126
| +3% | +$511K | 0.74% | 48 |
|
|
2016
Q1 | $20.3M | Sell |
195,474
-4,442
| -2% | -$432K | 0.88% | 39 |
|
|
2015
Q4 | $19.5M | Sell |
199,916
-17,322
| -8% | -$1.7M | 0.84% | 39 |
|
|
2015
Q3 | $21M | Buy |
217,238
+12,246
| +6% | +$1.29M | 0.93% | 36 |
|
|
2015
Q2 | $21.5M | Buy |
204,992
+4,653
| +2% | +$475K | 0.93% | 36 |
|
|
2015
Q1 | $20.7M | Buy |
200,339
+8,150
| +4% | +$825K | 0.9% | 36 |
|
|
2014
Q4 | $18.5M | Buy |
192,189
+17,284
| +10% | +$1.52M | 0.84% | 38 |
|
|
2014
Q3 | $13.9M | Buy |
174,905
+3,603
| +2% | +$284K | 0.7% | 49 |
|
|
2014
Q2 | $12.9M | Buy |
171,302
+5,068
| +3% | +$383K | 0.65% | 51 |
|
|
2014
Q1 | $12.4M | Sell |
166,234
-3,612
| -2% | -$255K | 0.69% | 49 |
|
|
2013
Q4 | $12.2M | Buy |
169,846
+2,070
| +1% | +$133K | 0.68% | 51 |
|
|
2013
Q3 | $9.52M | Sell |
167,776
-16,451
| -9% | -$980K | 0.62% | 62 |
|
|
2013
Q2 | $10.5M | Buy |
+184,227
| New | +$10.7M | 0.63% | 53 |
|
Other funds holding CVS
Avalon Investment & Advisory's CVS Position: Q1 2023 in Review
Avalon Investment & Advisory increased its CVS Health (CVS) stake by 0.43% in Q1 2023, buying an estimated $76.1K and bringing the position to 210,163 shares worth $15.6M. The position accounts for 0.43% of the portfolio, ranked #73.
Avalon Investment & Advisory first reported a position in CVS in Q2 2013 and has held it in 38 quarters since. The position peaked at $53.9M in Q4 2021. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.
- Avalon Investment & Advisory held 210,163 shares of CVS Health worth $15.6M as of Q1 2023.
- Avalon Investment & Advisory bought 908 CVS Health shares in Q1 2023, an estimated $76.1K.
- CVS Health made up 0.43% of Avalon Investment & Advisory's portfolio in Q1 2023, its #73 holding.
- Avalon Investment & Advisory first reported a position in CVS Health in Q2 2013 and has held it in 38 quarters since.
- Avalon Investment & Advisory's CVS Health position peaked at $53.9M in Q4 2021.
- 2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.
Based on Avalon Investment & Advisory's 13F filing for Q1 2023, filed 15 May 2023.